NRX Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.58-$3.84 |
Market Cap | $55.8M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $242,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $145,000 |
Diluted EPS | -$2.31 |
News
See moreYahoo Finance • 3 months ago
NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation
Yahoo Finance • 3 months ago
NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine
Yahoo Finance • 3 months ago
NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call
About
CEO | Dr. Jonathan C. Javitt M.D., M.P.H. |
Address | 1201 Orange Street, Wilmington, DE, United States, 19801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
